On July 15, 2024 Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya"), The Spatial Biology Company, reported that it will release financial results for the second quarter of 2024 after the market closes on Monday, August 5, 2024 (Press release, Akoya Biosciences, JUL 15, 2024, View Source [SID1234644865]). Company management will host a conference call to discuss financial results at 5:00 p.m. ET.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the "Investors" section of the Akoya website at View Source
Akoya also announced that management will be presenting or doing fireside chats at two upcoming investor conferences.
Canaccord Genuity 44th Annual Growth Conference
Tuesday, August 13 at 2:30 PM ET
Morgan Stanley 22nd Annual Global Healthcare Conference
Friday, September 6 at 1:05 PM ET
A live and archived webcast of the events will be available on the "Investors" section of the Akoya website at View Source